Plasmalogens rescue neuronal cell death through an activation of AKT and ERK survival signaling

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Hossain, Md Shamim ^a   Ifuku, Masataka ^a   Take, Sachiko ^a   Kawamura, Jun ^b   Miake, Kiyotaka ^b   Katafuchi, Toshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Central Research Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE 3; CASPASE 9; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PLASMALOGEN; PROTEIN KINASE B; PROTEIN SERINE KINASE; THREONINE PROTEINASE; UO 126; CASPASE; RETINOIC ACID;

ANIMAL CELL; ARTICLE; BRAIN CELL; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; IN VITRO STUDY; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PROTEIN CLEAVAGE; SIGNAL TRANSDUCTION; STARVATION; ANIMAL; APOPTOSIS; CELL DEATH; CYTOLOGY; DRUG EFFECTS; METABOLISM; NERVE CELL; PHOSPHORYLATION; PROTEIN DEGRADATION; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CASPASES; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HIPPOCAMPUS; MICE; NEURONS; PHOSPHORYLATION; PLASMALOGENS; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRETINOIN;

EID: 84893341891     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083508     Document Type: Article

References (45)

1. Nagan N, Zoeller RA (2001) Plasmalogens: biosynthesis and functions. Prog Lipid Res 40: 199-229. doi:10.1016/S0163-7827(01)00003-0. PubMed: 11275267.
2. Gorgas K, Teigler A, Komljenovic D, Just WW (2006) The ether lipiddeficient mouse: tracking down plasmalogen functions. Biochim Biophys Acta 1763: 1511-1526. doi:10.1016/j.bbamcr.2006.08.038. PubMed: 17027098.
3. Ifuku M, Katafuchi T, Mawatari S, Noda M, Miake K et al. (2012) Anti-inflammatory/anti-amyloidogenic effects of plasmalogens in lipopolysaccharide-induced neuroinflammation in adult mice. J Neuroinflammation 9: 197. doi:10.1186/1742-2094-9-197. PubMed: 22889165.
4. Katafuchi T, Ifuku M, Mawatari S, Noda M, Miake K et al. (2012) Effects of plasmalogens on systemic lipopolysaccharide-induced glial activation and beta-amyloid accumulation in adult mice. Ann N Y Acad Sci 1262: 85-92. doi:10.1111/j.1749-6632.2012.06641.x. PubMed: 22823439.
5. Farooqui AA, Horrocks LA (2001) Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia. Neuroscientist 7: 232-245. doi:10.1177/107385840100700308. PubMed: 11499402.
6. Braverman NE, Moser AB (2012) Functions of plasmalogen lipids in health and disease. Biochim Biophys Acta 1822: 1442-1452. doi:10.1016/j.bbadis.2012.05. 008. PubMed: 22627108.
7. Moser AB, Steinberg SJ, Watkins PA, Moser HW, Ramaswamy K et al. (2011) Human and great ape red blood cells differ in plasmalogen levels and composition. Lipids Health Dis 10: 101. doi:10.1186/1476-511X-10-101. PubMed: 21679470.
8. Albi E, Viola Magni MP (2004) The role of intranuclear lipids. Biol Cell 96: 657-667. doi:10.1016/j.biolcel.2004.05.004. PubMed: 15519699.
9. Weller S, Gould SJ, Valle D (2003) Peroxisome biogenesis disorders. Annu Rev Genomics Hum Genet 4: 165-211. doi:10.1146/annurev.genom.4.070802.110424. PubMed: 14527301.
10. Wanders RJ, Waterham HR (2005) Peroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disorders. Clin Genet 67: 107-133. PubMed: 15679822.
11. Murphy EJ, Schapiro MB, Rapoport SI, Shetty HU (2000) Phospholipid composition and levels are altered in Down syndrome brain. Brain Res 867: 9-18. doi:10.1016/S0006-8993(00)02205-8. PubMed: 10837793.
12. Hartmann T, Kuchenbecker J, Grimm MO (2007) Alzheimer's disease: the lipid connection. J Neurochem 103 Suppl 1: 159-170. doi:10.1111/j.1471-4159. 2007.04715.x. PubMed: 17986151.
13. Khan M, Singh J, Singh I (2008) Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin. J Neurochem 106: 1766-1779. PubMed: 18540993.
14. Mawatari S, Yunoki K, Sugiyama M, Fujino T (2009) Simultaneous preparation of purified plasmalogens and sphingomyelin in human erythrocytes with phospholipase A1 from Aspergillus orizae. Biosci Biotechnol Biochem 73: 2621-2625. doi:10.1271/bbb.90455. PubMed: 19966491.
15. Hermann C, Assmus B, Urbich C, Zeiher AM, Dimmeler S (2000) Insulin-mediated stimulation of protein kinase Akt: A potent survival signaling cascade for endothelial cells. Arterioscler Thromb Vasc Biol 20: 402-409. doi:10.1161/01.ATV.20.2.402. PubMed: 10669636.
16. Allan LA, Morrice N, Brady S, Magee G, Pathak S et al. (2003) Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat Cell Biol 5: 647-654. doi:10.1038/ncb1005. PubMed: 12792650.
17. Kitazumi I, Tsukahara M (2011) Regulation of DNA fragmentation: the role of caspases and phosphorylation. FEBS J 278: 427-441. doi:10.1111/j.1742-4658. 2010.07975.x. PubMed: 21182594.
18. Meister B, Fink FM, Hittmair A, Marth C, Widschwendter M (1998) Antiproliferative activity and apoptosis induced by retinoic acid receptor-gamma selectively binding retinoids in neuroblastoma. Anticancer Res 18: 1777-1786. PubMed: 9673404.
19. Masetti R, Vendemini F, Zama D, Biagi C, Gasperini P et al. (2012) Alltrans retinoic acid in the treatment of pediatric acute promyelocytic leukemia. Expert Rev Anticancer Ther 12: 1191-1204. doi:10.1586/era.12.101. PubMed: 23098119.
20. Fujita E, Soyama A, Kawabata M, Momoi T (1999) BMP-4 and retinoic acid synergistically induce activation of caspase-9 and cause apoptosis of P19 embryonal carcinoma cells cultured as a monolayer. Cell Death Differ 6: 1109-1116. doi:10.1038/sj.cdd.4400585. PubMed: 10578180.
21. Siddikuzzaman, Guruvayoorappan C, Berlin Grace VM (2011) All trans retinoic acid and cancer. Immunopharmacol Immunotoxicol 33: 241-249. doi:10.3109/08923973.2010.521507. PubMed: 20929432.
22. Wood PL, Mankidy R, Ritchie S, Heath D, Wood JA et al. (2010) Circulating plasmalogen levels and Alzheimer Disease Assessment Scale-Cognitive scores in Alzheimer patients. J Psychiatry Neurosci 35: 59-62. doi:10.1503/jpn.090059. PubMed: 20040248.
23. Ginsberg L, Rafique S, Xuereb JH, Rapoport SI, Gershfeld NL (1995) Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain. Brain Res 698: 223-226. doi:10.1016/0006-8993(95) 00931-F. PubMed: 8581486.
24. Han X, Holtzman DM, McKeel DW Jr. (2001) Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J Neurochem 77: 1168-1180. doi:10.1046/j.1471-4159.2001.00332.x. PubMed: 11359882.
25. Ginsberg L, Xuereb JH, Gershfeld NL (1998) Membrane instability, plasmalogen content, and Alzheimer's disease. J Neurochem 70: 2533-2538. PubMed: 9603219.
26. Guan Z, Wang Y, Cairns NJ, Lantos PL, Dallner G et al. (1999) Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. J Neuropathol Exp Neurol 58: 740-747. doi:10.1097/00005072-199907000-00008. PubMed: 10411344.
27. Goodenowe DB, Cook LL, Liu J, Lu Y, Jayasinghe DA et al. (2007) Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia. J Lipid Res 48: 2485-2498. doi:10.1194/jlr.P700023-JLR200. PubMed: 17664527.
28. Oma S, Mawatari S, Saito K, Wakana C, Tsuboi Y et al. (2012) Changes in phospholipid composition of erythrocyte membrane in Alzheimer's disease. Dement Geriatr Cogn Dis Extra 2: 298-303. doi:10.1159/000341603. PubMed: 22962553.
29. Farooqui AA (2010) Studies on plasmalogen-selective phospholipase A2 in brain. Mol Neurobiol 41: 267-273. doi:10.1007/s12035-009-8091-y. PubMed: 20049656.
30. Hossain MS, Ifuku M, Katafuchi T (2013) Role of ceramide in the physiology and pathophysiology of nervous systems. Adv Neuroimmun Biol 4: 35-44.
31. Rothhaar TL, Grosgen S, Haupenthal VJ, Burg VK, Hundsdorfer B, et al. (2012) Plasmalogens inhibit APP processing by directly affecting gamma-secretase activity in Alzheimer's disease. ScientificWorldJournal 2012: 141240.
32. Zubiaur M, Fernández O, Ferrero E, Salmerón J, Malissen B et al. (2002) CD38 is associated with lipid rafts and upon receptor stimulation leads to Akt/protein kinase B and Erk activation in the absence of the CD3-zeta immune receptor tyrosine-based activation motifs. J Biol Chem 277: 13-22. PubMed: 11689561.
33. Gasperi V, Dainese E, Oddi S, Sabatucci A, Maccarrone M (2013) GPR55 and its interaction with membrane lipids: comparison with other endocannabinoid- binding receptors. Curr Med Chem 20: 64-78. PubMed: 23151004.
34. Chang L, Chiang SH, Saltiel AR (2004) Insulin signaling and the regulation of glucose transport. Mol Med 10: 65-71. PubMed: 16307172.
35. Simons K, Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1: 31-39. doi:10.1038/35036205. PubMed: 11413487.
36. Nakagawa T, Zhu H, Morishima N, Li E, Xu J et al. (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403: 98-103. doi:10.1038/47513. PubMed: 10638761.
37. Shibata M, Hattori H, Sasaki T, Gotoh J, Hamada J et al. (2003) Activation of caspase-12 by endoplasmic reticulum stress induced by transient middle cerebral artery occlusion in mice. Neuroscience 118: 491-499. doi:10.1016/S0306-4522(02)00910-7. PubMed: 12699784.
38. Oubrahim H, Wang J, Stadtman ER, Chock PB (2005) Molecular cloning and characterization of murine caspase-12 gene promoter. Proc Natl Acad Sci U S A 102: 2322-2327. doi:10.1073/pnas.0409874102. PubMed: 15701691.
39. Krajewska M, You Z, Rong J, Kress C, Huang X et al. (2011) Neuronal deletion of caspase 8 protects against brain injury in mouse models of controlled cortical impact and kainic acid-induced excitotoxicity. PLOS ONE 6: e24341. doi:10.1371/journal.pone.0024341. PubMed: 21957448.
40. Valverde AM, Mur C, Brownlee M, Benito M (2004) Susceptibility to apoptosis in insulin-like growth factor-I receptor-deficient brown adipocytes. Mol Biol Cell 15: 5101-5117. doi:10.1091/mbc.E03-11-0853. PubMed: 15356271.
41. Viswanath V, Wu Y, Boonplueang R, Chen S, Stevenson FF et al. (2001) Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease. J Neurosci 21: 9519-9528. PubMed: 11739563.
42. Jiang X, Wang X (2000) Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J Biol Chem 275: 31199-31203. doi:10.1074/jbc.C000405200. PubMed: 10940292.
43. Datta SR, Dudek H, Tao X, Masters S, Fu H et al. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231-241. doi:10.1016/S0092-8674(00)80405-5. PubMed: 9346240.
44. Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, et al. (2004) JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 18: 189-218.
45. Gross A, McDonnell JM, Korsmeyer SJ (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911. doi:10.1101/gad.13.15.1899. PubMed: 10444588.